Publiziert in: Marktpuls, Unternehmen
Frei

Reminder: Invitation to Roche’s Virtual Pharma Day - Monday, 14th September 2020 Mittwoch, 19. August 2020 - 10:34

Investor Update  ?v=02122019070000
 Reminder: Invitation to Roche's Virtual Pharma Day - Monday, 14th September 2020
 

e85edd7e-919c-40a7-a6a0-81741cf36a8b

The Investor Relations team would like to invite you to Roche's Virtual Pharma Day 2020 that will take place as a live video webcast on

Monday, 14th September
14:00 – 17:15 CEST / 13:00 - 16:15 BST
8:00 – 11:15 am EDT / 5:00 - 8:15 am PDT

The event will address the following topics:

  • Pharma strategy, Culture and organization, Productivity and new technologies
  • Market opportunities, Launches, Pricing & Access, PHC & Digitalisation
  • Late stage pipeline: Oncology, Neuroscience, Immunology, Ophthalmology, Infectious diseases (special focus HBV)


Speakers will include:

  • Bill Anderson, Chief Executive Officer Roche Pharmaceuticals
  • Teresa Graham, Head of Pharma Global Product Strategy
  • Levi Garraway, Chief Medical Officer and Head Global Product Development
  • Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
  • Cristin Hubbard, Head I2O (Immunology, Infectious Diseases, Ophthalmology) Global Product Strategy
  • John Young, Global Head of Infectious Diseases, Roche Pharma Research & Early Development


Live video webcast will start with presentations, followed by Q&A (live access to the speakers).

Access to live event
Please pre-register for our webinar 
here.*

A replay of the webcast will be available via > 
ir.roche.com

*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations and Roche Group Planning



Bruno Eschli
Investor Relations Officer

Roche Investor Relations

 

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: 
karl.mahler@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: 
jon_kaspar.bayard@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: 
sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: 
bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: 
birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: 
gerard.tobin@roche.com

 

 

Investor Relations North America

 

Loren Kalm
Phone: +1 650 225 3217
e-mail: 
kalm.loren@gene.com

Dr. Lisa Tuomi
Phone: +1 650 467 8737
e-mail: 
tuomi.lisa@gene.com

 

 

 

All rights reserved ©2020 F. Hoffmann-La Roche Ltd.
Group Communications, Grenzacherstrasse 124, CH-4070 Basel, Switzerland